Bain Capital Life Sciences Investors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-657
| Closed | -$39.7K | – | 31 |
|
|
2023
Q3 | $39.7K | Sell |
657
-25,312
| -97% | -$1.53M | ﹤0.01% | 31 |
|
|
2023
Q2 | $2.65M | Sell |
25,969
-35,266
| -58% | -$3.59M | 0.27% | 30 |
|
|
2023
Q1 | $10.8M | Sell |
61,235
-13,655
| -18% | -$2.41M | 1.35% | 21 |
|
|
2022
Q4 | $29M | Buy |
74,890
+1,349
| +2% | +$522K | 3.24% | 10 |
|
|
2022
Q3 | $24.8M | Hold |
73,541
| – | – | 2.96% | 11 |
|
|
2022
Q2 | $24.2M | Buy |
+73,541
| New | +$24.2M | 2.83% | 11 |
|